Results 1 to 10 of about 5,604 (216)

Immune-Mediated Necrotizing Myopathy: An Often Misdiagnosed Entity [PDF]

open access: goldEuropean Journal of Case Reports in Internal Medicine, 2015
Immune-mediated necrotizing myopathies (IMNM) are recognized as a subgroup of idiopathic inflammatory myopathies (IIM). IMNM are defined based on a combination of clinical presentation and laboratory studies, requiring a specific myopathological pattern ...
Joana Almeida Espírito Santo   +4 more
doaj   +8 more sources

Treatment of refractory immune-mediated necrotizing myopathy with efgartigimod [PDF]

open access: goldFrontiers in Immunology
ObjectiveWe aimed to explore the efficacy and safety of efgartigimod in patients with refractory immune-mediated necrotizing myopathy (IMNM).MethodsThis open-label pilot observational study included seven patients with refractory IMNM, all of whom ...
MengTing Yang   +11 more
doaj   +5 more sources

Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies [PDF]

open access: goldAntibodies
Immune-mediated necrotizing myopathy (IMNM) is a rare and severe disease that corresponds to a specific entity of idiopathic inflammatory myopathy. Patients with IMNM suffer from proximal muscle weakness, and present high levels of creatine kinase and ...
Sarah Julien   +5 more
doaj   +6 more sources

Pediatric immune-mediated necrotizing myopathy [PDF]

open access: yesFrontiers in Neurology, 2023
Immune-mediated necrotizing myopathy (IMNM) is a type of inflammatory myopathy. Most patients with IMNM produce anti-3-hydroxy-3-methylglutaryl coenzyme A reductase or anti-signal-recognition particle autoantibodies.
Chen-Hua Wang   +4 more
doaj   +4 more sources

MRI patterns of thigh muscle involvement in immune-mediated necrotizing myopathy and dermatomyositis [PDF]

open access: goldBMC Rheumatology
Background Immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM) are characterized by weakness, hyperCKemia, associated autoantibodies, and varying extramuscular manifestations.
Anson W. Wilks   +5 more
doaj   +3 more sources

Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country [PDF]

open access: goldReports
Background and Clinical Significance: Tuberculosis (TB) poses a significant global health challenge; although low–middle income countries carry the heaviest burden, its diagnosis and treatment can be challenging in any country.
Agnese Colpani   +5 more
doaj   +3 more sources

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy [PDF]

open access: goldScientific Reports
Anti-HMGCR-positive immune-mediated necrotizing myopathy (IMNM), also anti-HMGCR myopathy, was initially considered as an exclusively skeletal muscular disease, observed in elderly patients with an acute onset.
Yuyan Cao   +14 more
doaj   +4 more sources

Beyond the Generalized Weakness: A Rare Case of Statin-Induced Immune-Mediated Necrotizing Myopathy [PDF]

open access: goldJournal of Investigative Medicine High Impact Case Reports
Statin-induced immune-mediated necrotizing myopathy (IMNM) is a rare subtype of idiopathic inflammatory myopathy associated with statin exposure and characterized by positive anti-hydroxymethylglutaryl coenzyme A reductase antibodies. Here, we describe a
Leo Sakai DO   +2 more
doaj   +3 more sources

Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy [PDF]

open access: goldDiagnostics, 2021
Immune-mediated necrotizing myopathy, a new subgroup of inflammatory myopathies, usually begins with subacute onset of symmetrical proximal muscle weakness.
Sunha Park   +3 more
doaj   +2 more sources

Anti-HMGCR positive immune-mediated necrotizing myopathy with associated neutrophilic urticarial dermatosis: A case report [PDF]

open access: goldJAAD Case Reports
Kathleen M. Fletcher, MD   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy